F-group (family)
70.3.1.1 SET
Ligands and drugs
1,306
Member domains
454
with ligand contacts (≤ 4 Å)
34.8% of members
389
with DrugDomain annotations
29.8% of members
332
with a DrugBank compound
25.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 70.3.1.1 belongs to X-group 70 beta-clip, which binds 7.9 ligand superclasses per 20 proteins, broader than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01752 | SAH | S-adenosyl-L-homocysteine | 161 |
| DB00118 | SAM | Ademetionine | 132 |
| DB01910 | SFG | Sinefungin | 20 |
| DB03345 | BME | Mercaptoethanol | 7 |
| DB00123 | LYS | Lysine | 2 |
| DB00130 | GLN | L-Glutamine | 2 |
| DB14799 | CJD | PF-06821497 | 2 |
| DB00434 | C7H | Cyproheptadine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 265 |
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 189 |
| SAM | S-ADENOSYLMETHIONINE | 158 |
| UNX | UNKNOWN ATOM OR ION | 40 |
| SFG | SINEFUNGIN | 30 |
| CL | CHLORIDE ION | 12 |
| SCN | THIOCYANATE ION | 10 |
| BME | BETA-MERCAPTOETHANOL | 8 |
| 7KZ | N4-(1-methylpiperidin-4-yl)-N2-hexyl-6,7-dimethoxyquinazoline-2,4-diamine | 6 |
| 90P | N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine | 6 |
| A1CXM | N~2~-[(7M)-6-fluoro-7-(2,5,6,7-tetrahydro-1H-azepin-4-yl)-2,3-dihydro-1-benzofuran-5-yl]-N~4~,6-dimethylpyrimidine-2,4-diamine | 6 |
| 0N6 | (R)-(3-(3-cyanophenyl)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide | 4 |
| 1L4 | N-[(2R)-3-(3-cyanophenyl)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-8-fluoro-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide | 4 |
| 6BN | 5,8-dichloro-2-[(4-ethyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-({1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl}oxy)-3,4-dihydroisoquinolin-1(2H)-one | 4 |
| 74D | 1-[(1~{R})-1-[1-[2,2-bis(fluoranyl)propyl]piperidin-4-yl]ethyl]-~{N}-[(4-methoxy-6-methyl-2-oxidanylidene-3~{H}-pyridin-3-yl)methyl]-2-methyl-indole-3-carboxamide | 4 |
| 7L6 | 6,7-dimethoxy-N-(1-methylpiperidin-4-yl)-2-(morpholin-4-yl)quinazolin-4-amine | 4 |
| 9HG | N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine | 4 |
| 9HJ | 6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)-N~2~-propylquinazoline-2,4-diamine | 4 |
| E67 | 7-[(5-aminopentyl)oxy]-N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine | 4 |
| E72 | 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine | 4 |